Browse studies

Find your next paid study

3,226 recruiting studies matching your filters

Investigation of Bone-Lead Level Associations With Brain and Mental Health and Treatment Response Among MUSC Psychiatry Patients

The goal of this study is to assess cumulative lead exposure among treatment-seeking patients in the MUSC hospital system receiving experimental transcranial m…

Lead Exposure

Estimated

~$10 – $750

Actual pay is set by the research site.

Medical University of South CarolinaNCT05887934

Phase 1

A Feasibility Study of Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma

This phase I trial studies the safety and side effects of glofitamab plus a chemoimmunotherapy regimen called R-CHOP (rituximab, cyclophosphamide, doxorubicin,…

Estimated

~$150 – $2,700

Actual pay is set by the research site.

Phase 1

A Feasibility Study of E7 TCR-T Cell Induction Therapy for Locoregionally Advanced HPV-Associated Cancers

The goal of this study is to determine the feasibility of administration of a single dose of E7 TCR-T cells as induction therapy prior to definitive treatment …

HPV-Associated Cervical CarcinomaHPV-Related CarcinomaHPV-Related Malignancy+14 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Observational

A Community-Based Approach for ALDH2 Genetic Testing in East Asian Americans

The goal of this clinical trial is to learn whether education plus genetic testing for ALDH2\*2 and ADH1B\*2 is feasible and acceptable and whether it influenc…

Healthy AdultFlushing

Estimated

~$10 – $750

Actual pay is set by the research site.

Northwestern UniversityNCT07392775

Phase 1

Phase I/IIa, Open-label Study to Evaluate Safety, Tolerability and Preliminary Efficacy of Modified Salmonella Typhimurium SGN1 in Patients With Advanced Solid Tumor

Objectives:To assess the safety and tolerability followed by a dose expansion study to characterize safety, and preliminary efficacy of SGN1 in participants wi…

Advanced Solid Tumor

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Guangzhou Sinogen Pharmaceutical Co., LtdNCT05038150

Phase 2

Aspirin and PAClitaxel in Recurrent/Metastatic PI3K Altered Head & Neck Squamous Cell Carcinoma (HNSCC): APAC

This is a phase II trial of aspirin and paclitaxel in patients with recurrent/metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) who have received …

Head and Neck (HNSCC)Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Head and Neck Squamous Cell Carcinoma+1 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Washington University School of MedicineNCT07901803

Phase 1

A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors

Researchers are looking for new ways to treat people with certain advanced solid tumors. Advanced means the cancer has spread to other parts of the body and ca…

Advanced Solid TumorsMalignant Neoplasm

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT06818643

Observational

Negotiation Training to Optimize Caregiver Communication in Alzheimer's Disease

Family caregivers of people living with Alzheimer's disease and related dementias often experience conflicts and communication challenges when coordinating car…

Alzheimer's Disease (AD)DementiaCognitive Impairment

Estimated

~$10 – $750

Actual pay is set by the research site.

Northwestern UniversityNCT07859540

Phase 1

A First-in-human, Multicentre, Phase Ia Dose Escalation Study of BI 3968621 as Monotherapy and in Combination With Ezabenlimab to Investigate Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumour Activity in Patients With Advanced Solid Tumours

This study is open to adults with advanced cancer that cannot be removed by surgery or have spread to other parts of the body. The purpose of this study is to …

Advanced Solid Tumour

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Boehringer IngelheimNCT07851103

Phase 1

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

This is a Phase 1/2, open-label, multicenter study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics and anti-tumor activity of TER-2013 …

Breast CancerEndometrial CancerOvarian Cancer+5 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Terremoto Biosciences Inc.NCT07109726

Phase 2

A Phase 2 Pivotal Study of BCB-276, a B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma

This study will evaluate BCB-276, an investigational B7-H3-targeted Chimeric Antigen Receptor (CAR) T cell therapy, in children and young adults with diffuse i…

Diffuse Intrinsic Pontine GliomaDIPGBrain Tumor+9 more

Estimated

~$75 – $2,800

Actual pay is set by the research site.

BrainChild Bio, IncNCT07680439

Phase 2

A Phase II Trial of T Cell Receptor Gene Therapy Targeting Human Papillomavirus ( HPV) 16 E7 for HPV-Associated Cancers

This is a phase II clinical trial to assess the clinical activity of immunotherapy with E7 TCR-T cells for metastatic HPV-associated cancers. HPV-associated ca…

Cervical CancerThroat CancerOropharynx Cancer+18 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.